• Nephrology Conferences - World Nephrology 2022 Scientific Committee is grateful to welcome you all to attend 18th World Nephrology Conference which will be apprehended during May 16-17, 2022 Tokyo, Japan. 18th World Nephrology Conference will increase the most active and latest issues in the field of Nephrology. The meeting will highlight the dialogue around the theme “The impact of COVID-19 on nephrology” by connecting the gaps between the academics from across the globe towards educate their research and outcomes by World Nephrology 2022. The highpoints of the conference include Nephrology, Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD), Kidney Transplantation, Dialysis and Renal Care, Paediatric Nephrology, Diabetic Nephropathy and many The aim of World Nephrology 2022 is to collective Researchers, Academicians and Scientists from the Nephrology communal and to produce an avenue in the path of energetic exchange of information scheduled practical advances, new scientific realizations, and the helpfulness of several show the way platforms just before Nephrology at this occasion. (Added: Tue Nov 09 2021 Hits: 19 Rating: 0.00 Votes: 0) Rate It

• 11th American Nursing, Healthcare Management, and Patient Safety Conference - 11th American Nursing, Healthcare Management, and Patient Safety Conference When: November 15-17, 2022 Where: San Francisco, United States Short Name: #AmericanNHPSUCG2022 Make sure to reserve your slot here: https://nursing.universeconferences.com/american-nursing-conferences-register-now Attending the 11th American Nursing, Healthcare Management, and Patient Safety Conference is an excellent way to be part of the change, professional development advancement, learn from healthcare research experts, and have a voice in the professional practice of research nursing, patient safety, and healthcare. Interacting through an online platform is easy, but a face-to-face meeting is still vital in this digital era for professionals and students. Submit your abstract here: https://nursing.universeconferences.com/american-nursing-conferences-call-for-paper/ San Francisco is one of America’s most vibrant cities that attract visitors from all over the world due to its attractive beauty. After visiting this beautiful city, millions of individuals leave their hearts out in San Francisco, and hence it is the most voted city by travelers. Important Updates; Group Discount is Available (5+Members) The 11th American Nursing, Healthcare Management, and Patient Safety Conference attract over 1000+ attendees every year. Submit your Proposal to speak at an in-person conference event today More Details: https://nursing.universeconferences.com/american-nursing-conferences Email: nursing@universeconferences.net Important Information: 11th American Nursing, Healthcare Management, and Patient Safety Conference Short Name: AmericanNHPSUCG2022 Dates: November 15-17, 2022 Venue: San Francisco, United States Email: nursing@universeconferences.net Visit: https://nursing.universeconferences.com/american-nursing-conferences Call for Papers: https://nursing.universeconferences.com/american-nursing-conferences-call-for-paper/ Register here: https://nursing.universeconferences.com/american-nursing-conferences-register-now Call/WhatsApp Us: +442033222718 Target Audience; Front-Line Staff, Officers, Directors, Vice-Presidents, C-Level Executives, Physicians, Nurses, Medical Assistants, Pharmacists, Professors, Researchers, Policy Makers, Consultants, Patient Advocates, Chief Executive/Director/Associate Director/Assistant Director/Chief/Chair/Non-Clinical Director/Medical Director. Clinical Lead/Senior Clinical Health Practitioner/Head Of Clinical Service Delivery, Consultant/Senior Consultant/ /Consultant Anaesthetist, Doctor, Surgeon, Head Of Education And Training/Clinical Lead For Training And Development/Director Of Hr, Education And Training, Head Of Clinical Governance/Governance And Risk Manager/Clinical Governance And Reporting Manager, Head Of Nursing/Director Of Nursing/ Director Of Nursing And Patient Safety/ Director Of Nursing And Quality, Patient Safety Lead/Patient Safety Manager/Head Of Quality/Quality Lead/Manager Of Quality Improvement, Infection Prevention Lead, Staff Nurse/Advanced Nurse Practitioner/Patient Safety Nurse/Ward Nurse/Clinical Nurse/Head Of Midwifery/Midwife/Matron/Matron In Charge/Charge Nurse, General Practitioner, Pharmacist, Patient Representatives, Academic- Including Researchers, Professors, And Students AmericanNHPSUCG2022-SUPPORTING JOURNALS Unified Citation Journals is a platform for the latest discoveries in Technology, Science, engineering, medicine, medical clinical, and advancing discoveries and health. We at Unified Citation Journals ensure the advancement of healthcare and improve performance for the benefit of humanity. Unified Citation Journals empower and publish scientific research work. We will be including special issues and symposia papers in related journals from all over the world. Apart from publishing, we also promote upcoming books covering different fields of science, medicine, engineering, technology, etc. Unified Citation Journals help Authors, Publishers, and Distributors, in growing their business multifold. More details: https://ucjournals.com/ Submit your e-posters today! ePoster Community is a medium of electronic presentation of your scientific posters that allow you to present and publish the latest scientific research work of your interest in front of worldwide viewers, learners, and open access community. An ePoster is worth a thousand words; it’s self-explanatory – it stands on its own and does most of your explanation digitally. We welcome researchers to submit their posters and make it visible. ePosters can contain many different rich resources such as research work, case reports, presentations, company profiles, assignments, images, trending news, projects, summary, results, apps, links, etc. More details: https://eposters.universeconferences.com/ ------------------------------ Community: Utilitarian Conferences Gathering Reg. No. 12330203 Registered at UCG, 12 Constance Street, London, England, E16 2DQ, UK Utilitarian Conferences Gathering, Company Reg. No. 12330203 Registered at UCG, 12 Constance Street, London, England, E16 2DQ, UK. Utilitarian Conferences Gathering offers a wide range of events, Meetings, Conferences, Workshops, symposiums. We have a dedicated team who are aimed at acquiring the technologies, adopting the knowledge of business needs, and accelerating with the best ideas and strategies. Utilitarian Conferences Gathering is a pioneer in the area of Event Management, Collaboration. We are a full-service event provider specializing in the field of Medical, Clinical, Healthcare, Life Sciences, Engineering, Pharma, Environmental Science, Engineering, Business, Agricultural, and Food event services for Academic and Industrial Sectors. We stand out distinctively from our competitors for our commitment to quality, round-the-clock service, and unmatched price. We are able to provide you with the best event, Meeting experience under one roof. We at Utilitarian Conferences Gathering make sure that you as a client choose the most appropriate event. More Information: https://universeconferences.com/ https://twitter.com/UCGConferences Facebook: https://www.facebook.com/utilitarianconferences.gathering.7 (Added: Tue Nov 09 2021 Hits: 20 Rating: 0.00 Votes: 0) Rate It

• End Stage Renal Disease Market, Size, Share 2021-2028 - Market Overview End-stage renal diseases are associated with disorders related to the kidney and occur during chronic kidney disease, which adversely affects the functioning of the kidney. The global end stage renal disease market size was valued US$ YY million in 2020 and is estimated to reach US$ YY million by 2028, growing at a CAGR of YY % during the forecast period (2021-2028). Market Dynamics Technological advancement products developed by the market players for renal diseases are expected to drive the market growth. Chronic kidney failure, also known as end-stage renal disease, causes the kidneys to lose function over time, which can be harmful. Most renal failure patients go to dialysis clinics numerous times a week to have their blood filtered, a time-consuming, painful, and dangerous procedure. KidneyX is a public-private partnership established by the US Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) to accelerate kidney disease prevention, diagnosis, and treatment innovation. The Kidney Project, led by Shuvo Roy, Ph.D. of UC San Francisco and William Fissell, MD of Vanderbilt University Medical Center (VUMC), successfully implanted the smartphone-sized device for the preclinical evaluation of two essential components parts of its artificial kidney, the hemofilter and the bioreactor. KidneyX's Phase 1 Artificial Kidney Prize was presented to the team, one of six winning teams chosen from a worldwide competition for this advancement. Moreover, the Kidney Project successfully tested the hemofilter, which removes waste products and toxins from the blood and the bioreactor, which simulates other kidney functions such as blood electrolyte balancing, in independent studies. The artificial kidney developed by The Kidney Project will imitate the exceptional quality of life experienced by kidney transplant recipients—the "gold standard" of kidney disease treatment—and improve on it. Additionally, In March 2021, Baxter International Inc. announced the US Food and Drug Administration (FDA) clearance of its next-generation Artificial Kidney 98 dialysis machine, which is designed to be a portable and easy-to-use system to administer hemodialysis (HD) treatments. Therefore, it indicated that companies are taking initiatives to establish a strong footprint and launch technologically advanced products in the market. Risks associated with the hemodialysis treatment are expected to hamper the market growth. Certain risks associated with hemodialysis treatment increase when patients undergo HHD alone since no one is there to assist them in the event of a medical emergency. Patients may lose consciousness or become physically unable to rectify the health emergency if needles come out, blood is lost, or blood pressure is very low during solo HHD. During any health emergency, losing consciousness or becoming otherwise disabled could result in serious damage or death. Moreover, due to the length of treatment duration and the fact that therapy is administered when the patient and care partner are asleep, the dangers associated with hemodialysis treatment increase while doing nocturnal therapy. Blood access disconnects and blood loss during sleep, blood clotting due to decreased blood flow or greater treatment time, and delayed response to alarms while waking from sleep are only a few of the hazards. Therefore, ancillary devices and training are required when performing solo HHD COVID-19 Impact Analysis The COVID-19 outbreak has significantly impacted kidney disease incidence and management, including AKI, ESKD, GN, and kidney transplantation. Initial data from China revealed that patients with COVID-19 had a decreased risk of AKI. However, recent studies from North America show a significantly greater incidence, which is likely owing to the higher frequency of concomitant diseases such as hypertension, diabetes, and CKD. Moreover, those who receive outpatient in-center HD are in close contact with other patients and staff multiple times a week, putting them at even greater risk. Clinical presentation is atypical compared with patients not on dialysis, with patients with ESKD presenting without typical symptoms of cough and fever but fatigue and anorexia. The risk of in-hospital death is significantly higher among patients with ESKD than patients without ESKD, with older age and the need for mechanical ventilation increasing risk. Additionally, the pandemic is interrupting the medical supply chain, and many companies will vary to other geographic regions in the future to ensure that products remain available and protect their supply chain. However, the situation is expected to improve gradually in the forecast period Segment Analysis -By End User • Hospital and Clinics* • Dialysis Centres • Others -By Treatment And Diagnosis Treatment • Kidney Transplantation Dialysis • Peritoneal Dialysis • emodialysis • Wearable Artificial Kidney Diagnosis • Blood Test • Urine Test • Imaging test • Others Geographical Analysis Asia-Pacific region holds the largest market share in the global end stage renal disease market In 2020, Asia-Pacific accounted for the highest revenue share. The growth in the aging population, lifestyle stress, a large population base, improving quality of diagnosis, and growing patient affordability, presence of high disposable income and the high acceptance rate of technologically improved products and raising blood pressure and diabetes cases in the region are some of the factors due to which the market is expected to boost in the forecast period. For instance, according to the Asian Diabetics Prevention Initiatives, Asia will account for 60 percent of the world's diabetes population by 2020. A bigger contribution from China and India had 113.9 million and 65.1 million adults with diabetes, respectively. Both China and India may have nearly half a billion diabetic people by 2030. Moreover, a report released by the Indian Government's national health portal indicates that 2.2 lakh new patients with end-stage renal disease (ESRD) are diagnosed each year, resulting in a demand for 3.4 crore dialysis treatments. In India, there were approximately 4,950 dialysis centers, most of which were in the private sector. As a result, the presence of several dialysis clinics in this region and an increase in the number of patients suffering from chronic renal and kidney illnesses are expected to boost market growth over the forecast period. Competitive Landscape Major key players in the end-stage renal disease market are B Braun Melsungen AG, Baxter International Inc, Medtronic PLC, Fresenius SE & Co. KGaA, Nipro Corporation, Asahi Kasei Medical Co., Trivitron Healthcare, Guangzhou MeCan Medical Limited, JMS North America Corporation and NxStage Medical. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which contribute to the growth of the end-stage renal disease market globally. For instance, In June 2021, Baxter launched the Sharesource Analytics 1.0 Digital Health Module to enhance the clinical management of home dialysis patients. NxStage Medical, Inc.: Overview: NxStage Medical, Inc. is an American company that develops, manufactures, and markets systems to treat chronic kidney disease, acute kidney injury, and hypervolemia. It is a subsidiary of Fresenius Medical Care. Product Portfolio: System One: The NxStage System One is the portable hemodialysis system specifically designed for patients in their homes and is small enough to travel and bring their treatment supplies. View Full Report: https://www.datamintelligence.com/research-report/end-stage-renal-disease-market Enquiry Before Buying: https://www.datamintelligence.com/enquiry/end-stage-renal-disease-market About Us DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world. For more information: Sai Kiran Sales Manager at DataM Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com (Added: Mon Nov 08 2021 Hits: 12 Rating: 0.00 Votes: 0) Rate It

• Bovine Lactoferrin Market, Size, Share, Growth, Trends 2021-2028 - Market Overview The global bovine lactoferrin market size was valued at US$ YY million in 2020 and is estimated to reach US$ YY million by 2028, growing at a CAGR of YY % during the forecast period (2021-2028). Lactoferrin protein can be found in both human and cow milk. Bovine lactoferrin (bLF) has been shown to have anti-infective, anti-cancer, and anti-inflammatory properties when consumed. Oral bLF, in particular is effective against infections of both digestive and non-digestive tract tissue in a variety of animal models. Download Free Sample: https://www.datamintelligence.com/download-sample/bovine-lactoferrin-market Market Dynamics The development of the immune system and the benefits associated with bovine lactoferrin are estimated to drive the market. The development of the immune system is estimated to drive the bovine lactoferrin market Lactoferrin is regarded to be the most polyvalent protein in vertebrate tissue defence against infections and traumas. It possesses antibacterial capabilities and affects innate and adaptive immune responses due to the proclivity of its basic N-terminal domain to interact with multiple microbial and host targets. Lactoferrin can influence immune cell activation, migration, and proliferation in both positive and negative ways. While lactoferrin's immunomodulatory effects have been demonstrated in vivo utilising lactoferrin deletion, lactoferrin-overexpressing transgenic animals, and dietary lactoferrin, few pathways have been postulated on in vitro research. While lactoferrin's immunomodulatory effects have been demonstrated in vivo utilising lactoferrin deletion, lactoferrin-overexpressing transgenic mice, and dietary lactoferrin, few mechanisms have been proposed to explain these properties based on in vitro research. Recent studies in humans provided evidence that oral supplementation with lactoferrin contributed to immune stimulation. The lactoferrin-based product increases immunological activities via inducing TGF and Wnt signalling pathways, as well as many genes encoding molecular effectors involved in the innate immune response, according to the study. Lysozymes (which mediate antibacterial defence by cleaving bacterial cell walls), saposins (peptides with antibacterial activity that create ion channels in target cell membranes), and lectins are all members of this gene family (proteins involved in pathogen detection). The benefits associated with the use of bovine lactoferrin is estimated to drive the market Bovine lactoferrin (bLF) has been shown to have anti-infective, anti-cancer, and anti-inflammatory properties when consumed. Oral bLF, in particular has shown to be effective against infections of both digestive and non-digestive tract tissue in a variety of animal models. Furthermore, clinical trials on individuals with Helicobacter pylori infection, chronic hepatitis, tinea pedis, and other disorders have shown that bLF has beneficial effects. Immunomodulation in the intestinal and systemic locations may mediate the protective effects of oral bLF against infection. Recently it was established that oral bLF has antiviral properties in influenza virus-infected mice. The amount of infiltrating leukocytes in the bronchoalveolar lavage fluid was reduced after BLF treatment. Using the quantitative RT-PCR method, oral bLF on the transcription of genes associated with immunity in the small intestine of mice was studied. The expression of IL-12p40, IFN-beta, and NOD2 was observed to be elevated after consuming bLF. As a result, oral bLF promotes the transcription of key immune-related genes in the small intestine, potentially promoting systemic host immunity. Side effects associated with lactoferrin is estimated to hamper the bovine lactoferrin market Lactoferrin, in the amounts found in food, is likely safe. Consuming larger levels of lactoferrin up to a year from cow's milk is possibly safe. For up to 14 days, human lactoferrin generated from specifically processed rice appears to be safe. Lactoferrin has the potential to cause diarrhoea. Skin rash, loss of appetite, weariness, cold, and constipation have all been recorded in high doses. High amounts of lactoferrin can cause diarrhoea, chills, weariness, loss of appetite, and constipation, among other things. People are concerned about mad cow disease since lactoferrin can be obtained from cows. The proper daily dosage of derived from dietary supplements is between 10 and 1200mg. To be safe, seek advice from a healthcare practitioner about a dosage that is appropriate for particular age, health state, and nutritional requirements. COVID-19 Impact Analysis Lactoferrin (LF) is a harmless iron-binding glycoprotein found in the milk of most animals. It has antiviral activity across a wide range of viruses, including coronaviruses. LF also has anti-inflammatory, anti-infective, and immune-regulating capabilities in line with SARS-CoV-2 infection therapy requirements. As a result, LF may be useful in the prevention and treatment of COVID-19. Furthermore, compared with other antiviral drugs, LF has a better safety profile. The use of LF may therefore hold promising results in the treatment of COVID-19 and warrants further investigation. Hence, there is an estimated scope for it in the market. Segment Analysis By Type • Spay dried powder* • Freeze dried powder By Application • Infant formula* • Dietary supplements • Pharmaceutical • Others Geographical Analysis North America region is estimated to dominate the bovine lactoferrin market The FDA approval and presence of major key players in this region are estimated to dominate the market. The US FDA recently cleared lactoferrin for use in infant formula. The demand value of U.S. lactoferrin was about 57.26 tons and is forecasted to increase to about 111.8 tons by 2025. Bovine lactoferrin (bLf) concentration in milk is normally about 100 mg/L (with the range of 70–120 mg/L). Owing to the availability of many cows in this region, the supply of bovine lactoferrin will be more. In the 24 major states the number of milk cows on farms was 8.94 million head 88,000 head more than February 2020, and 2,000 head more than January 2021. In the United States the number of milk cows on farms was 9.46 million, 81,000 head more than February 2020 and 3,000 head more than January 2021. Hence, this region is estimated to dominate the market due to the presence of many cows. Competitive Landscape Major key players present in the global bovine lactoferrin market are Fonterra Group, Bega Cheese, FrieslandCampina (DMV), Milei Gmbh, Glanbia Nutritionals, Westland Milk, Tatua, Synlait Milk, WBC, Murray Goulburn and Ingredia Nutritional Fonterra Group Overview: Fonterra Cooperative Group is the world's largest dairy exporter, a leader in dairy research and innovation, the owner of a considerable portfolio of Asian Pacific brands, and a partner to many of the world's leading food companies. Fonterra has offices in more than 40 countries across the world with its headquarters in New Zealand. Product Portfolio: The company comprises Dairy, Nutrition and Dairy Ingredients. Key Development: In 2020, Fonterra Australia signed an agreement to buy Dairy Country to help the company's premier Australian cheese division become more efficient. View Full Report: https://www.datamintelligence.com/research-report/bovine-lactoferrin-market Enquiry Before Buying: https://www.datamintelligence.com/enquiry/bovine-lactoferrin-market About Us DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world. For more information: Sai Kiran Sales Manager at DataM Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com (Added: Mon Nov 08 2021 Hits: 13 Rating: 0.00 Votes: 0) Rate It

• 23-Valent Pneumococcal Polysaccharide Vaccine Market, Size, Share 2021-2028 - Market Overview Pneumococcal is an infectious disease affected by the streptococcus pneumoniae bacteria, which may cause different illnesses such as ear infections, meningitis, and others. Pneumococcal polysaccharide vaccines are advised mostly for adults who suffer from pneumococcal infection. The global 23-valent pneumococcal polysaccharide vaccine market size was valued US$ YY billion in 2020 and is estimated to reach US$ YY billion by 2028, growing at a CAGR of YY % during the forecast period (2021-2028) Download free sample: https://www.datamintelligence.com/download-sample/23-valent-pneumococcal-polysaccharide-vaccine-market Market Dynamics Growing number of pneumococcal diseases associated with chronic disease patients is expected to drive the market growth. According to the American Lung Association, Pneumococcal pneumonia is a potentially serious disease that can cause a range of different illnesses, including sinusitis, otitis media, pneumonia, bacteremia, osteomyelitis, septic arthritis and meningitis. Sinusitis affects 1 out of every seven adults in the United States, with more than 30 million individuals diagnosed each year. Moreover, the immune system naturally weakens with age, so even if you're healthy and active, being 65 or older is a key risk factor for pneumococcal pneumonia leading to an increased risk of chronic conditions, including COPD, Asthma, and heart disease Disease and Diabetes. Therefore it has led to an increase in the demand for the 23-Valent pneumococcal polysaccharide vaccine, which is expected to drive the market in the forecast period. Side effects of PNEUMOVAX 23 (Pneumococcal Vaccine Polyvalent) are expected to hamper the market growth. According to Merck, PNEUMOVAX 23 is a vaccine that is given as a shot. It helps protect from infection by certain germs or bacteria, which are called pneumococcus. Moreover, Pneumovax 23 vaccine is important for preventing infection in individuals at risk, including those with heart disease, lung disease, liver disease, kidney disease, diabetes, alcoholism, cirrhosis, spleen problems, sickle cell anemia, HIV, certain cancers, adults over 65 years of age. But the vaccine may not protect everyone who gets it, and it will not protect against diseases caused by bacteria types that are not in the vaccine. Besides the benefits of the vaccine, there are few side effects, including pain, warmth, soreness, redness, swelling, and hardening at the injection site, headache, weakness and feeling tired, and muscle pain. Thus, from the above statements, the market is expected to get hampered in the forecast period. COVID-19 Impact Analysis The coronavirus disease 2019 (COVID-19) pandemic is associated with high morbidity and mortality. Evidence shows that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, is originally transmitted through respiratory droplets from symptomatic, asymptomatic, or pre-symptomatic individuals. Like other respiratory pathogens, such as influenza, where approximately 25% of older patients get secondary bacterial infections, both superinfections and co-infections with SARS-CoV-2 have been reported. However, there is limited data on the frequency of co-infection and superinfections by viral, bacterial, or fungal infections and associated clinical outcomes among patients infected with SARS-CoV-2. Moreover, the co-infection acts as the recovery of other respiratory pathogens in patients with SARS-CoV-2 infection at the time of a SARS-CoV-2 infection diagnosis and superinfection as the subsequent recovery of other respiratory pathogens during care for SARS-CoV-2 infection. Two previous reviews have examined the prevalence of bacterial and fungal co-infection or superinfection in SARS-CoV-2 infected patients. In addition, prior work suggests outcome differences in patients with co-infections vs. superinfections. For instance, Garcia-Vidal et al. showed that SARS-CoV-2 infected patients with superinfections had a longer hospital stay (LOS) and higher mortality. In contrast, those with co-infections had a higher frequency of admission to the ICU. Diagnostic testing and therapeutic decision-making may be altered by the presence of co-infection or superinfection with SARS-CoV-2 and other respiratory pathogens. Additionally, the market faces challenges in manufacturing and delivering drugs due to an interrupted supply chain. Providing essential services due to lockdowns has led to reduced supply to the end-users. The pandemic is not likely to have long-term effects on end-users primary growth in the 23-valent pneumococcal polysaccharide vaccine market. Segment Analysis – By Age-Group • Children (2-10 years)* • Adults (10-64 years) • Geriatrics (65 years and above) – By Dose Type • Single Dose Vial* • Pre-Filled Syringe Geographical Analysis North America region holds the largest market share in the global 23-valent pneumococcal polysaccharide vaccine market. North America accounted for the largest revenue share in 2020. The growth is attributed to the high prevalence of bacterial pneumonia, well established vaccination program in the region, increasing prevalence of diseases, growing adoption of advanced vaccines, and large pool of key players, the largest supplier and consumption market of 23-valent pneumococcal polysaccharide vaccine, are the major factors that the market is expected to boost the forecast period. For instance, according to the American Lung Association, The most common type of bacterial pneumonia is called pneumococcal pneumonia. Pneumococcal pneumonia is caused by the Streptococcus pneumoniae germ that normally lives in the upper respiratory tract. It infects over 900,000 Americans every year. The greatest risk for bacterial pneumonia includes people recovering from surgery, people with respiratory disease or viral infection, and weakened immune systems. Moreover, it causes more than a million hospitalizations and more than 50,000 deaths each year. Therefore, it has increased the demand for the 23-Valent pneumococcal polysaccharide vaccine, due to which the North American region is expected to hold the largest market share in the forecast period. Competitive Landscape The 23-valent pneumococcal polysaccharide vaccine market is vast with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc, Merck & Co., AstraZeneca, Baxter International Inc., Biogen Inc., Serum Institute of India, Eli Lilly and Company and Beijing Minhai Biotechnology. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the 23-valent pneumococcal polysaccharide vaccine market globally. Merck & Co.: Overview: Merck & Co., Inc., outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891. The company develops and produces medicines, vaccines, biological therapies and animal health products. It has multiple blockbuster drugs or products, each with 2020 revenues, including cancer immunotherapy, anti-diabetic medication and vaccines against HPV and chickenpox. Moreover, the company is ranked 69th on the 2021 Fortune 500 and 92nd on the 2021 Forbes Global 2000, both based on 2020 revenues View full report: https://www.datamintelligence.com/research-report/23-valent-pneumococcal-polysaccharide-vaccine-market Enquiry before buying: https://www.datamintelligence.com/enquiry/23-valent-pneumococcal-polysaccharide-vaccine-market About Us DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world. For more information: Sai Kiran Sales Manager at DataM Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com (Added: Mon Nov 08 2021 Hits: 14 Rating: 0.00 Votes: 0) Rate It

• free slot play - casino slot free slot machine free (Added: Sat Nov 06 2021 Hits: 32 Rating: 0.00 Votes: 0) Rate It

• Treatment for juvenile idiopathic arthritis in Karimnagar - Juvenile idiopathic arthritis is a common type of arthritis that affects children; it is earlier known as juvenile rheumatoid arthritis. Children under 16 years of age are mostly affected. It is a chronic disease that affects any joint of the body. The immune system mistakenly targets synovium (synovium is a tissue that lines the inside of the joint). The synovium responds by making excess synovial fluid which leads to persistent joint pain, swelling, and stiffness. The inflammation and synovium spreads to the surrounding tissues and damage cartilage and bone. Some children may see the early symptoms only for a few months, while others have symptoms lifelong. Some categories of juvenile idiopathic arthritis can give rise to critical problems, such as growth and development problems, joint damage, and eye inflammation. Treatment is given to reduce pain and inflammation, improving the function of the joints, and preventing any further joint damage. There are many types of Juvenile idiopathic arthritis they are: - Systemic arthritis, Oligoarthritis, Polyarthritis, Psoriatic arthritis, Enthesitis-related arthritis. Symptoms of JIA: Depends on the type of JIA, the symptoms vary. Common symptoms are Morning stiffness: you might have noticed that your child is unable to walk especially in the morning. Pain: the child appears clumsier than usual mainly in the mornings and after taking nap. Swelling and tenderness in the joints: it is mostly noticed in the larger joints such as knee. Limping, fever, rash, weight loss, fatigue, eye redness, and blurred vision: these symptoms usually worsen in the evenings. Based on the symptoms and the number of joints affected the type of disease is identified. Symptoms come and go over days or weeks. When the child has less fever it seems to be fine. When it flares up, the child will feel sick. Children will have good days with very few or without any symptoms, and worse days with flare up symptoms.This condition might cause inflammation in the lining of the lung (pleuritis) or heart (pericarditis). It may also cause swollen lymph nodes. Children with these conditions may grow slowly than normal. Causes: Juvenile idiopathic arthritis occurs when our own body's immune system attacks its own cells and tissues. Research indicates that it is an autoimmune disease. White blood cells can’t tell the difference between healthy cells and germs. Instead of protecting from these harmful invaders, it damages healthy tissues and cause inflammation and pain. It's unknown why this happens, but both heredity and environment seem to play a vital role in causing the disease. Certain gene mutations may make a person more vulnerable to environmental factors like viruses that are the triggering source of the disease. (Added: Fri Nov 05 2021 Hits: 20 Rating: 0.00 Votes: 0) Rate It

• Best Doctor for Sjogrens Syndrome in Warangal - Sjögren’s syndrome is an autoimmune disease in which our own body immune system attacks glands that produce moisture. The misdirected immune system leads to inflammation of tissues and dysfunction in glands of the body that are generating tears and saliva. Sjogren syndrome affects lacrimal glands which produce tears and salivary glands which produce saliva in the mouth. It causes extreme dryness of eyes and mouth. Causes: The cause of Sjögren’s syndrome is not known, your immune system mistakenly attacks your own body cells and tissues instead of attacking harmful bacteria and viruses. It’s very commonly found in some families who have members with other autoimmune problems, such as systemic lupus erythematosus, autoimmune thyroid disease, type I diabetes, etc. women are mostly affected by this autoimmune disease. Symptoms: Symptoms of Sjogrens syndrome are different from person to person. The symptoms and signs are extreme Mouth dryness, Swallowing difficulties, Dental decay, Cavities, Gum disease, Mouth sores and swelling, Hoarseness or impaired voice, Abnormality of taste or loss of taste, Dry cough, and Stones and/or infection of the parotid gland inside of the cheeks, Eye dryness, Eye irritation, Less tear production, feeling of a foreign object in the eye, burning sensation in the eye, it can harm the cornea, which is your eye’s clear outer layer. It can also affect other parts in the body; you may feel dryness in the throat, nose, lips or skin. The glands which are in the face and neck may get swollen. Some women may feel dryness in their vagina. Some people may have similar symptoms of rheumatoid arthritis such as stiffness in their joints and pain, though they don’t have the disease. Diagnosis: Your doctor may diagnose Sjögren’s syndrome after observing dryness of the eyes and mouth, and running tests are done to detect the presence of the condition. One such test is Schirmer’s test, it is done to measure the eye’s ability to wet a slip of paper. Other examinations are done to determine the presence of Sjögren’s syndrome by testing the production of saliva and antibodies, as well as dryness on the surface of the eye. Blood test: blood tests are done to check the levels of different types of blood cells, to check if you have germ fighting proteins that many with sjogren syndrome people have. Blood tests can also measure the inflammation in the body. To know if you have high amounts of proteins called immunoglubulins, which are part of your infection fighting system. Imaging tests: These tests are done to find the functioning of salivary glands. Sailogram: A dye is injected into the salivary glands in front of your ears and a special X-ray shows how much saliva flows into your mouth. Salivary scintigraphy: you will be given a low level radioactive marker and will be positioned under a gamma scintillation camera that detects the radiation and produces an image. This is to see how quickly it arrives in all your salivary glands. Biopsy: Lip Biopsy is performed to check the presence of clusters of inflammatory cells. (Added: Fri Nov 05 2021 Hits: 24 Rating: 0.00 Votes: 0) Rate It

• Castrate Resistant Prostate Cancer Therapeutics Market - Market Overview •The Global Castrate Resistant Prostate Cancer Therapeutics Market is expected to grow at a CAGR of 8.4% during the forecasting period (2021-2028). •Castration-resistant prostate cancer is stated as prostate cancer that is scattered to other parts of the body. There are several risk factors for castration-resistant prostate cancer, including genetic predisposition, unhygienic diet, geriatric population, medication exposure, and many sexual partners. The methods were available for the diagnosis for detection of castration-resistant prostate cancer, which includes prostate imaging, tumor marker, biopsy, and staging test. For CRPC treatment, docetaxel-based chemotherapy has been widely accepted by urologists and oncologists. Download free sample: https://www.datamintelligence.com/download-sample/castrate-resistant-prostate-cancer-therapeutics-market (Added: Wed Nov 03 2021 Hits: 20 Rating: 0.00 Votes: 0) Rate It

• Best Ayurveda Specialists Consultation at Your Fingertips with Ayurmegha - "Ayurveda made Simple And Accessible, We bring highly qualified Ayurveda doctors around the globe to your doorstep. By providing the ability to book video appointments, make payments, shop & receive supplements from the comfort of your home. Trusted, Secure & Authentic Ayurveda Video consultations with leading Ayurveda vaidyas. Ayurmegha is an exclusive platform that brings reputed Ayurveda doctors to your doorstep. We also deliver Ayurveda medicines to your doorstep from reputed GMP and Ayush certified Ayurveda manufacturers. You just have to visit our website to submit your query and your session will be booked with the best doctors within no time." (Added: Wed Nov 03 2021 Hits: 22 Rating: 0.00 Votes: 0) Rate It

• International Hair Society elects Dr Kapil Dua from India as Vice President - Lisbon, Portugal: International Society for Hair Restoration Surgery, USA, elected Dr Kapil Dua as Vice President for the new term. The announcement came at ISHRS’s 29thWorld Congress being held in Lisbon, Portugal. Dr Kapil Dua, who earlier became the only doctor from India to be on the Board of Governors, was elected based on his contribution to the cause of making hair transplant more ethical & result oriented. The ISHRS is an international, non-profit medical society comprised of over 1,000 members representing 70 countries – dedicated to promulgating the highest standards of medical practice and medical ethics in the field of Hair Restoration especially Hair Transplant. Dr Kapil Dua on the occasion vowed that he would do his best to contribute to the field and especially to the ISHRS initiative – ‘Fight-the-Fight’, wherein the international society had declared war on unethical practices, unlicensed physicians and established international standards in India as well. (Added: Wed Nov 03 2021 Hits: 22 Rating: 0.00 Votes: 0) Rate It

• Comprehensive Exosome Profiling Platforms Regarding Exosomal Contents - Harnessing advanced exosome profiling technology at Creative Biolabs to overcome challenges in the detection, isolation, and analysis of exosomes and their contents. The cargo that exosomes contain, including nuclear acids, proteins, lipids, and cytokines, has proven to be potential for cancer diagnostics and the determination of other diseases. However, the small size of exosomes and complex biological environment are technically challenging their molecular detection and analysis, which means exosome isolation is necessary prior to investigating exosomes and expanding their application potentials. Exosomes exist in plant and animal cells, such as B cells, dendritic cells, and tumor cells, as well as in almost all biological fluids, including plasma, urine, serum, cerebrospinal fluid (CSF), ascites, and saliva. Researchers can isolate exosomes from a variety of cellular debris and interfering components using methods like differential ultracentrifugation, ultrafiltration, precipitation, exosomes capture based on membrane affinity, and isolation based on microfluidic technology. Scientists at Creative Biolabs, a biotech company deeply engaged in exosome-related services and products for decades, have developed multiple exosome profiling platforms to isolate, purify, quantify, and analyze molecular contents after isolating the required exosomes. For Exosomal RNA Isolation and Profiling Exosomes can deliver nucleic acid cargo such as total RNA, mRNA, microRNAs, lncRNAs, and circRNAs for communication between cells. These exosome contents can be extracted using different methods, for example, phenol-based techniques and column-based techniques, after which preliminary characterization is also essential for extracted exosomal RNA. An efficient exosomal RNA profiling platform is developed for the isolation, identification, and properties analysis of RNA contents in exosomes. For Exosomal Protein Isolation and Profiling Another content that exosomes can recruit and transport based on different cellular origins is cellular proteins, which have been studied as potential biomarkers for cancer, liver diseases, and kidney diseases. Thus, the development of exosomal protein isolation and profiling platform could advance the downstream applications of exosomal proteins including ELISA, protein mass spectrometry, protein biomarker verification, and gel analysis of exosomal proteins. For Exosomal cfDNA Isolation and Profiling cfDNA, the first detected nucleic acid in the bloodstream, could indicate cell death because cfDNA is believed to be released by dead cells into the blood based on known properties of cfDNA, for instance, its increase in cancer patients and many other disease states. Exosomal cfDNA profiling has become an important step in both fundamental research and clinical applications when it comes to disease diagnosis and novel therapy development. For Exosomal Cytokines Profiling The ability of exosomes to mediate communications between cells and the microenvironment also depends on cytokines, which are soluble factors secreted through exosomes to regulate immune function and inflammation. Exosomal cytokines profiling can provide multi-parameter analysis of exosomal-related cytokines, possibly identifying exosomes as novel biomarkers in cell-to-cell communication, inflammation, autoimmunity, and infectious disease pathology. The acquirement and interpretation of profiling data after exosome detection are technically supported by flow cytometry (FC) that can capture the immunomagnetic beads of exosomes, electron microscopy (EM) that can observe the pure and specialized exosomes based on the magnetic separation technology, and optical microscopy (OM) that can observe labeled exosome RNA or membrane components. About Creative Biolabs As a company specialized in exosome basic research and application, Creative Biolabs fulfills its mission by providing industry-leading exosomal products and services, striving to help researchers in their projects and advance exosome-related science. Find out more at: https://www.creative-biolabs.com/exosome/ (Added: Wed Nov 03 2021 Hits: 18 Rating: 0.00 Votes: 0) Rate It

• Dental Chair - Dentsply Waxit is a surface tension reducing agent for waxes and silicones, designed to improve casting and model surfaces. Waxit makes it possible for the investing compound to flow in easily. INDICATION Wetting Agent for Casting Wax Model. (Added: Tue Nov 02 2021 Hits: 14 Rating: 0.00 Votes: 0) Rate It

• Animal Genetics Market, Size, Share - Market Overview ●The Global Animal Genetics Market is expected to grow at a high CAGR during the forecasting period (2021-2028). ●Animal genetics includes the study of the heredity and variation in the farm, domestic and wild animals. It is the study of the inheritance, physical genetic traits, gene expression, and animal breeding. The animal genetics market is dominated by the availability of the several animal genetics products such as live animals, genetic material, and genetic testing services. Download free sample: https://www.datamintelligence.com/download-sample/animal-genetics-market. Market Dynamics ●The market is driven by the increasing demand for animal genetics for DNA testing, genetic trait testing, genetic disease traiting, and animal breeding applications. Animal genetics provide the several benefits such as cattle beef feeding, increasing seed stock and cattle production. Animal genetics is useful for the identification of the superior breeds in breeding to increase the high reproduction rate. The increasing consumption of the animal proteins based dietary supplements and food shall stimulate the market growth. There is increasing adoption of the advanced genetic technologies such as artificial insemination, embryo transfer, and others. There is growing awareness regarding the veterinary genetic diseases. ●The market is witnessing the manufacturing expansion for the production of the animal genetics products. For instance, in July 2018, Hy-Line International, the world leader in layer poultry genetics had launched the world’s largest layer hatchery by Huayu Agricultural Technology Co., Ltd., named the Huayu International Poultry Incubation Center. This hatchery has a production capacity of 60 million female commercial chicks annually. The hatchery equipment, design, construction and biosecurity are world-class. ●In February 2017, Novogen had launched a new GP site in Ile-et-Vilaine, France. The new building is built in a U shape across a total surface area of 1,920 m2. It has a capacity to hold about 13,000 Grand Parents in two houses measuring roughly 800m2 each which are equipped with central automated nest boxes. The integration of this new production site would enable the NOVOGEN to further increase the production area and to ensure that the clients are continuously supplied with the best quality products. ●In September 2017, Neogen Corporation had established an animal genomics facility at The University of Queensland Gatton campus in a move that would reinforce UQ’s capacity to support the livestock industry and animal breeders. ●Several organizations, institutes, and associations are working on the animal genetics. For instance, in August 2019, The International Livestock Research Institute (ILRI) had entered into the collaboration with the India’s National Institute of Animal Biotechnology (NIAB) to work together in livestock genetics and animal health research programs for human and livestock development in India. ●However, stringent regulations regarding animal genetic engineering shall hinder the market growth. The high cost of animal testing and lack of the skilled professionals for animal genetics could have a negative impact on the market. Segmentation Analysis ●The global animal genetics market is segmented based on the live animals as the porcine, bovine, poultry, canine, and others. Porcine segment accounts for the highest market share of XX% in 2019 due to the growing consumer base of pork and pork products. Pork is the most widely-eaten meat across the globe. Pork accounts for approximately 35% of the world's meat intake. There is increasing penetration of advanced genetic research for porcine. The limited land requirements and low maintenance for the porcine shall stimulate the market growth. ●The poultry segment is expected to have the positive market growth due to the increasing consumption of the white meat. There is increasing consumer shift from the red meat toward white meat. There is growing usage of the by-products of poultry as the manure. The poultry animals are creating robust economic value for livestock farmers. The domestic fowls, including chickens, turkeys, geese and ducks, raised for the production of meat or eggs. The pocket-friendliness and low rate of food-related disease transmissions are driving the genetic research related to the poultry. The animal genetics would help to boost white meat production to meet the growing demand of the white meat production. ●Further, the market is also classified based on the genetic materials as embryo, and semen. The embryo segment accounts for the highest market share of XX% in 2019 due to the higher efficiency of the embryo. Transfer of the embryos are useful for amplifying the reproduction rates. Embryo transfer are beneficial for larger-scale production and quality breeds. There is growing preference for genetic modification procedures due to the low cost of the importing the embryos. Embryos have the efficiency of changing the breed of the entire herd within a single generation. Geographical Share ●By region, the global animal genetics market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the global animal genetics market and is expected to grow at the highest CAGR during the forecasted period owing to the growing adoption of the advanced technologies in animal genetics. The advanced animal genetic technologies such as embryo transfer, artificial insemination (AI), and others are useful for improving the animal breeding for efficient growth and reproduction of the healthy animals. There is presence of the large number of the companies providing the animal genetic products and services. The growing awareness regarding the animal welfare shall stimulate the market growth. ●Asia-Pacific is expected to have the positive market growth due to the growing animal care services, both at veterinary hospitals and community-level centers. There is increasing livestock population across the region. There is increasing usage of the animal genetics for producing the animals with the most desirable traits. The genetic produce animals are able to produce more amount of the products and are less prone to the diseases. There is increasing research and development activities for producing the healthier food and milk products from livestock animals by genetic modifications. The growing demand for the animal-derived protein shall stimulate the market growth over the forecasted period. Competitive Landscape ●The global animal genetics market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition. Neogen Corporation, URUS, Genus Plc., Groupe Grimaud, EW Group GmbH, Zoetis, Animal Genetics, Vetgen are the leading market players with significant market share. The major players are using product development, novel product launches, market expansion, and product diversification strategies for holding their position in the market. ●The companies are entering into the collaborations, mergers, strategic partnerships, and acquisitions to increase the demand for Animal Genetics and their expansion across the globe. For instance, In September 2018, Neogen Corporation had acquired the assets of Livestock Genetic Services, LCC, a Virginia-based company that specializes in genetic evaluations and data management for cattle breeding organizations. This acquisition would enhance the company’s in-house genetic evaluation capabilities, and complements the company's unparalleled global network of animal genomics laboratories. ●In May 2018, Recombinetics, a Minnesota company had entered into the collaboration with the Canadian semen distributor Semex to help bring more polled genetics into dairy cattle breeding. The alliance would help the company to utilize precision breeding in an effort to eliminate dehorning. This collaboration would increase the amount of the polled cattle with high-merit dairy genetics. ●In November 2017, Genus IntelliGen Technologies, a unit of Genus had announced a technology transfer and license agreement of its proprietary sexed genetics technology to Geno, the leading Norwegian bovine genetics producer. Under the terms of the agreement, Geno would produce sexed Norwegian Red genetics in Norway using Genus’ innovative genetics sexing technology. ●In May 2016, Genus plc, a global pioneer in animal genetics had entered into the multi-year strategic collaboration with the Caribou Biosciences, Inc., a leader in the revolutionary field of CRISPR-Cas gene editing. Under the terms of the agreement, Genus would receive a worldwide, exclusive license to Caribou’s leading CRISPR-Cas9 gene editing technology platform in certain livestock species. This partnership would position Caribou at the forefront of an emerging market for which CRISPR-Cas9 could have profound benefits to animal welfare and society. This partnership would further strengthen Genus' leadership in applying gene editing technology to improve animal health and well-being. It would provide Caribou with opportunities within the animal genetics space and a novel gateway to apply its technology to help improve the welfare of food-producing animals. ●In January 2013, Scidera Genomics LLC had been acquired by a Lansing, Mich. based Neogen Corp. Scidera, formerly known as Metamorphix Inc., pioneered developing of animal genetic testing in cattle, poultry, swine and dogs. Under the terms of the agreement, Scidera would be the part of the Neogen’s animal safety segment. Report Scope ●Understand the current market scenario and viability of animal genetics market over the forecast period. ●Visualize the composition of the global animal genetics market products in terms of live animals, genetic materials, and services highlighting the critical commercial assets and players. ●Identify commercial opportunities in the global animal genetics market by analyzing trends and co-development deals. View full report: https://www.datamintelligence.com/research-report/animal-genetics-market. Enquiry before buying: https://www.datamintelligence.com/enquiry/animal-genetics-market About Us DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world. For more information: Sai Kiran Sales Manager at DataM Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com (Added: Tue Nov 02 2021 Hits: 21 Rating: 0.00 Votes: 0) Rate It

• Animal Genetics Market, Size, Share - Market Overview ●The Global Animal Genetics Market is expected to grow at a high CAGR during the forecasting period (2021-2028). ●Animal genetics includes the study of the heredity and variation in the farm, domestic and wild animals. It is the study of the inheritance, physical genetic traits, gene expression, and animal breeding. The animal genetics market is dominated by the availability of the several animal genetics products such as live animals, genetic material, and genetic testing services. Download free sample: https://www.datamintelligence.com/download-sample/animal-genetics-market. Market Dynamics ●The market is driven by the increasing demand for animal genetics for DNA testing, genetic trait testing, genetic disease traiting, and animal breeding applications. Animal genetics provide the several benefits such as cattle beef feeding, increasing seed stock and cattle production. Animal genetics is useful for the identification of the superior breeds in breeding to increase the high reproduction rate. The increasing consumption of the animal proteins based dietary supplements and food shall stimulate the market growth. There is increasing adoption of the advanced genetic technologies such as artificial insemination, embryo transfer, and others. There is growing awareness regarding the veterinary genetic diseases. ●The market is witnessing the manufacturing expansion for the production of the animal genetics products. For instance, in July 2018, Hy-Line International, the world leader in layer poultry genetics had launched the world’s largest layer hatchery by Huayu Agricultural Technology Co., Ltd., named the Huayu International Poultry Incubation Center. This hatchery has a production capacity of 60 million female commercial chicks annually. The hatchery equipment, design, construction and biosecurity are world-class. ●In February 2017, Novogen had launched a new GP site in Ile-et-Vilaine, France. The new building is built in a U shape across a total surface area of 1,920 m2. It has a capacity to hold about 13,000 Grand Parents in two houses measuring roughly 800m2 each which are equipped with central automated nest boxes. The integration of this new production site would enable the NOVOGEN to further increase the production area and to ensure that the clients are continuously supplied with the best quality products. ●In September 2017, Neogen Corporation had established an animal genomics facility at The University of Queensland Gatton campus in a move that would reinforce UQ’s capacity to support the livestock industry and animal breeders. ●Several organizations, institutes, and associations are working on the animal genetics. For instance, in August 2019, The International Livestock Research Institute (ILRI) had entered into the collaboration with the India’s National Institute of Animal Biotechnology (NIAB) to work together in livestock genetics and animal health research programs for human and livestock development in India. ●However, stringent regulations regarding animal genetic engineering shall hinder the market growth. The high cost of animal testing and lack of the skilled professionals for animal genetics could have a negative impact on the market. Segmentation Analysis ●The global animal genetics market is segmented based on the live animals as the porcine, bovine, poultry, canine, and others. Porcine segment accounts for the highest market share of XX% in 2019 due to the growing consumer base of pork and pork products. Pork is the most widely-eaten meat across the globe. Pork accounts for approximately 35% of the world's meat intake. There is increasing penetration of advanced genetic research for porcine. The limited land requirements and low maintenance for the porcine shall stimulate the market growth. ●The poultry segment is expected to have the positive market growth due to the increasing consumption of the white meat. There is increasing consumer shift from the red meat toward white meat. There is growing usage of the by-products of poultry as the manure. The poultry animals are creating robust economic value for livestock farmers. The domestic fowls, including chickens, turkeys, geese and ducks, raised for the production of meat or eggs. The pocket-friendliness and low rate of food-related disease transmissions are driving the genetic research related to the poultry. The animal genetics would help to boost white meat production to meet the growing demand of the white meat production. ●Further, the market is also classified based on the genetic materials as embryo, and semen. The embryo segment accounts for the highest market share of XX% in 2019 due to the higher efficiency of the embryo. Transfer of the embryos are useful for amplifying the reproduction rates. Embryo transfer are beneficial for larger-scale production and quality breeds. There is growing preference for genetic modification procedures due to the low cost of the importing the embryos. Embryos have the efficiency of changing the breed of the entire herd within a single generation. Geographical Share ●By region, the global animal genetics market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the global animal genetics market and is expected to grow at the highest CAGR during the forecasted period owing to the growing adoption of the advanced technologies in animal genetics. The advanced animal genetic technologies such as embryo transfer, artificial insemination (AI), and others are useful for improving the animal breeding for efficient growth and reproduction of the healthy animals. There is presence of the large number of the companies providing the animal genetic products and services. The growing awareness regarding the animal welfare shall stimulate the market growth. ●Asia-Pacific is expected to have the positive market growth due to the growing animal care services, both at veterinary hospitals and community-level centers. There is increasing livestock population across the region. There is increasing usage of the animal genetics for producing the animals with the most desirable traits. The genetic produce animals are able to produce more amount of the products and are less prone to the diseases. There is increasing research and development activities for producing the healthier food and milk products from livestock animals by genetic modifications. The growing demand for the animal-derived protein shall stimulate the market growth over the forecasted period. Competitive Landscape ●The global animal genetics market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition. Neogen Corporation, URUS, Genus Plc., Groupe Grimaud, EW Group GmbH, Zoetis, Animal Genetics, Vetgen are the leading market players with significant market share. The major players are using product development, novel product launches, market expansion, and product diversification strategies for holding their position in the market. ●The companies are entering into the collaborations, mergers, strategic partnerships, and acquisitions to increase the demand for Animal Genetics and their expansion across the globe. For instance, In September 2018, Neogen Corporation had acquired the assets of Livestock Genetic Services, LCC, a Virginia-based company that specializes in genetic evaluations and data management for cattle breeding organizations. This acquisition would enhance the company’s in-house genetic evaluation capabilities, and complements the company's unparalleled global network of animal genomics laboratories. ●In May 2018, Recombinetics, a Minnesota company had entered into the collaboration with the Canadian semen distributor Semex to help bring more polled genetics into dairy cattle breeding. The alliance would help the company to utilize precision breeding in an effort to eliminate dehorning. This collaboration would increase the amount of the polled cattle with high-merit dairy genetics. ●In November 2017, Genus IntelliGen Technologies, a unit of Genus had announced a technology transfer and license agreement of its proprietary sexed genetics technology to Geno, the leading Norwegian bovine genetics producer. Under the terms of the agreement, Geno would produce sexed Norwegian Red genetics in Norway using Genus’ innovative genetics sexing technology. ●In May 2016, Genus plc, a global pioneer in animal genetics had entered into the multi-year strategic collaboration with the Caribou Biosciences, Inc., a leader in the revolutionary field of CRISPR-Cas gene editing. Under the terms of the agreement, Genus would receive a worldwide, exclusive license to Caribou’s leading CRISPR-Cas9 gene editing technology platform in certain livestock species. This partnership would position Caribou at the forefront of an emerging market for which CRISPR-Cas9 could have profound benefits to animal welfare and society. This partnership would further strengthen Genus' leadership in applying gene editing technology to improve animal health and well-being. It would provide Caribou with opportunities within the animal genetics space and a novel gateway to apply its technology to help improve the welfare of food-producing animals. ●In January 2013, Scidera Genomics LLC had been acquired by a Lansing, Mich. based Neogen Corp. Scidera, formerly known as Metamorphix Inc., pioneered developing of animal genetic testing in cattle, poultry, swine and dogs. Under the terms of the agreement, Scidera would be the part of the Neogen’s animal safety segment. Report Scope ●Understand the current market scenario and viability of animal genetics market over the forecast period. ●Visualize the composition of the global animal genetics market products in terms of live animals, genetic materials, and services highlighting the critical commercial assets and players. ●Identify commercial opportunities in the global animal genetics market by analyzing trends and co-development deals. View full report: https://www.datamintelligence.com/research-report/animal-genetics-market. Enquiry before buying: https://www.datamintelligence.com/enquiry/animal-genetics-market About Us DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world. For more information: Sai Kiran Sales Manager at DataM Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com (Added: Tue Nov 02 2021 Hits: 14 Rating: 0.00 Votes: 0) Rate It

• Carpal Tunnel Syndrome Treatment - Carpal tunnel syndrome is a common disorder that causes pain, numbness, tingling, and weakness in the hand and wrist. It occurs when there is a high amount of pressure within the wrist on a nerve called the median nerve. This median nerve provides sensation to the thumb, index, and middle fingers, and half of the ring finger. The little finger (the “pinky”) is typically not affected. This median nerve also provides strength to few muscles at the base of the thumb and index finger. Carpal tunnel: - Carpal tunnel is a narrow passage in the wrist. The bottom and sides of the tunnel are formed by small semi-circular bones called carpal bones. A tissue called ligament forms in the top of the tunnel. The median nerve and tendons pass through this space. These tendons connect muscles in the forearm to bones in the hand. These help the finger and thumb to bend and straighten. carpel Who is at risk? Women are three times more possible to have carpal tunnel syndrome than men. Carpal tunnel syndrome is mostly diagnosed between the ages of 30 and 60. Jobs that involve repetitive finger use, mainly those associated with high force, extreme wrist motions may develop this disorder. Many factors contribute to the development of carpal tunnel syndromes such as high salt intake, sedentary lifestyle and, obesity. People who work in professions like Manufacturing, Assembly line work, Keyboarding occupations, and Construction work are at greater risk. Causes: The carpal tunnel is a narrow passage in the wrist; it is surrounded by bones and ligaments. Tendons run through the carpal tunnel and help the fingers and the median nerve move, which is responsible for both sensation and movement in the hand, thumb, index finger, middle finger, and ring finger. Any condition that causes swelling of the membranes of the carpal tunnel can lead to the carpel tunnel syndrome. When the tissues of the carpal tunnel become swollen, it will cause the median nerve to be compressed, which is known as nerve entrapment. (Added: Tue Nov 02 2021 Hits: 13 Rating: 0.00 Votes: 0) Rate It

• Fibromyalgia Signs and Symptoms - Fibromyalgia is a disorder that affects the muscles and soft tissues. Symptoms of fibromyalgia are severe body pains, mental distress, joint pains like arthritis, fatigue; sleep problems, which can be managed through proper medications and lifestyle changes. These symptoms accumulate over a period of time due to many reasons such as physical trauma, surgery, infection or psychological stress. There is no particular reason for this problem. No lab tests or X-rays shows up the problem. Doctors diagnose it based on the symptoms. Fibromyalgia does not damage your joints or organs. Symptoms: The main symptom of fibromyalgia is muscle pain throughout the body, sleep problems, stiffness in joints and muscles in early hours, headache, irritable bowel syndrome, painful menstrual cramps, sensitivity to cold and heat, restless leg syndrome (RLS), fatigue, anxiety or depression, numbness or tingling. Fibromyalgia often comes with other painful conditions such as Migraine Interstitial cystitis or painful bladder syndrome pelvic and urinary problems nausea joint disorders problem while urination Who can get fibromyalgia? Women between 35 to 60 years of age have high chances of developing fibromyalgia. Women are more likely to get 10 times more than men. Even doctors aren’t sure about this. Causes: The exact cause of fibromyalgia is not known. However, present thinking in the arena of Rheumatology advises that fibromyalgia is a problem with central pain processing in the brain, where there may be an enlarged sensitivity or perception of pain to a given trigger. There are many factors that are included: Physical trauma such as car accident or any other. Genetics- women whose close relative with fibromyalgia have higher risk of developing the disorder. Repetitive injuries It may occur due to Rheumatoid arthritis or other autoimmune diseases, such as lupus joint disorders Central nervous system (CNS) problems (Added: Tue Nov 02 2021 Hits: 18 Rating: 0.00 Votes: 0) Rate It

• Paeonia Healthcare Pvt. Ltd. | ICU at home, Nursing Services at home - Paeonia Healthcare has proven track record of setting up ICU setup at home with Doctor recommended protocols and also providing home isolation and quarantine services. (Added: Sat Oct 30 2021 Hits: 12 Rating: 0.00 Votes: 0) Rate It

• Bhartiya Cryogas - In keeping with the heritage and glorious tradition of Bhartiya, a new division, Bhartiya Cryogas, an ISO Certified was established at the premises of Bhartiya Vehicles & Engineering Co. Ltd. during the year 2006. TYPES OF PLANTS BEING FABRICATED AND SUPPLIED BY BHARTIYA CRYOGAS: Bhartiya Cryogas has a distinction of undertaking each project as a comprehensive package, right from the design, fabrication, testing and commissioning on-site till they are fully operational. CRYOGENICS 1) Medium Pressure Oxygen/Nitrogen Gas/Liquid Plants 2) Low Pressure Oxygen/Nitrogen Gas/Liquid Plants PRESSURE SWING ADSORBPTION 1) PSA/VPSA Oxygen/Nitrogen Generators INDUSTRIAL GAS PLANTS 1) Hi-tech Acetylene plants 2) Nitrous Oxide plants 3) CO2 plants 4) Cylinder Filling Station CLIENTELE:- Over the preceding years, Bhartiya Cryogas has been duly acclaimed and recognized overseas for supplying and commissioning several oxygen/nitrogen, hi-tech acetylene, CO2 and nitrous oxide plants to a host of elite customers from mostly Southern America, Africa, Nigeria, Middle East and South East Asian countries. ACHIEVEMENTS:- Bhartiya Cryogas has been awarded "International Trophy for Quality (New Millennium Award)", International Golden Trophy for Quality (New Millennium Award) and “International Star Award for Quality (ISAQ) for the year 2011, at Geneva, Switzerland consecutively for three years on a trot as a recognition and promotion of the quality philosophy to achieve par excellence (Geneva Headquarter for the International Trophy for Quality, Switzerland). ROLE OF BHARTIYA CRYOGAS DURING 2ND WAVE OF PANDEMIC:- Recently the devastating second wave of Corona pandemic resulted into untimely shocking death of innumerable precious human beings primarily because of acute shortage of Medical Oxygen across the length and breadth of India including several countries worldwide. Therefore, Bhartiya Cryogas, leading manufacturer and supplier of customized Cryogenic and PSA Medical Oxygen Generation plant spontaneously accepted the challenge to fill in the void of shortfall of Medical PSA Oxygen Generator Plant. In this context, being the Founder CEO of Bhartiya Cryogas, let me put in record that within a short period of three months, Bhartiya Cryogas geared up their facilities on a war footing to design, fabricate and deliver customized highest quality standard Medical PSA oxygen Generation plants on a mission mode to several Government Hospitals PAN India, under the PM Cares objectives. Given the present scenario of impending third wave of Corona, dedicated team of Engineers are being deputed by Bhartiya Cryogas for commissioning these PSA plants to Government Hospitals located at Uttar Pradesh, Punjab, Maharashtra as part of the ongoing contractual obligations. FUTURE PROJECTS:- a) Oxygen Project at Sri Lanka for autonomous and continuous oxygen on-site for health care facilities. b) PSA Medical Oxygen Plants – Nigeria c) Cryogenic Liquid Medical Oxygen Plants at Brazil and Iran. d) Aquatic Pond Fishing Breathing System (Added: Sat Oct 30 2021 Hits: 18 Rating: 0.00 Votes: 0) Rate It

• Don't Delay Campaign Launched To Tackle Radon-Induced Lung Cancer - During UK Radon Awareness Week (1st – 7th Nov), experts are highlighting the impact that the COVID-19 pandemic has had on lung cancer detection, diagnosis and treatment times and urging members of the public not to delay taking steps to protect their lungs • A UK Lung Cancer Coalition report suggests that lung cancer is one of the worst affected cancer pathways due to a combination of factors, including overlapping symptoms with COVID-19 and specific pressures on respiratory health-care services caused by the pandemic. • According to an article published in the British Journal of Cancer, the pandemic is having profound effects on both diagnosis and treatment strategies • Don’t Delay campaign urges public to test homes for radon, the leading cause of lung cancer in non-smokers and to see their GP if they develop lung cancer symptoms • Radon is the leading cause of lung cancer after smoking and is responsible for over 1100 deaths in the UK every year. “During the first wave of the pandemic, public fear of engaging with health services, halting of the national programme of lung cancer screening pilots, and restricted access to diagnostic tests contributed to a 75% drop in urgent lung cancer referrals,” said Robert Rintoul, Chair of the UK Lung Cancer Coalition Clinical Advisory Group. “Guidance to stay at home with a cough, a key symptom of lung cancer, also caused further confusion among the general public. As a result of the reduction in referrals we are now seeing an increase in late-stage presentations which will potentially lead to hundreds of additional deaths, reversing the significant progress that has been achieved in improving lung cancer survival over the last 10–15 years.” In August 2021, the NHS launched its ‘Help Us, Help You’ campaign with the aim of persuading people exhibiting possible lung cancer symptoms to contact their GP. To further enhance this message, the UK Radon Association is today launching its Don’t Delay campaign. Rebecca Coates, Chair of UK Radon Association said, “Lung cancer is often still thought of as a smoker’s disease, however sadly rates in non-smokers are increasing. Lung cancer is not the immediate thought for a non-smoker with a persistent cough, even less so whilst COVID-19 is a possible cause. That’s why we’ve launched the Don’t Delay campaign to raise awareness not only of the need to visit your GP if you have symptoms, but also that everyone should consider testing their home for radon to protect their lungs.” Radon is a radioactive gas we can’t see, smell or taste. It comes from the rocks and soil found everywhere in the UK and can enter your building without you knowing. The only way to know if a building has a high radon level is to have it tested, which costs about £50. According to the UK Health Security Agency, radon produces tiny radioactive particles in the air we breathe which damages our lung tissue and, over a long period, may cause lung cancer. The higher the level and the longer the period of exposure, the greater the risk. At the recent UK Radon Symposium, keynote speaker Dr Aaron Goodarzi, Canada Research Chair for Radiation Exposure Disease drew attention to findings that previous lung disease, including pneumonia, bronchitis and COPD, leads to an increased risk of an individual developing lung cancer in the future. Dr Goodarzi warned that the number of patients suffering with so-called ‘Long Covid’ globally will have widespread ramifications on lung cancer rates. ENDS Contact: Rebecca Coates – UK Radon Association Chair chairman@radonassociation.co.uk or 07931 702948 Notes to Editors The Don’t Delay campaign video is available at https://youtu.be/Y27vOdz_LOE References Radon and Public Health - Report of the Independent Advisory Group on Ionising Radiation https://www.gov.uk/government/publications/radon-and-public-health COVID-19 Matters: A Review of the Impact of COVID-19 on the Lung Cancer Pathway and Opportunities for Innovation Emerging from the Health System Response to the Pandemic - https://www.uklcc.org.uk/wp-content/uploads/2020/10/UKLCC-COVID-19-Matters-Report-Oct-2020.pdf Lung cancer control in the UK hit badly by COVID-19 pandemic - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832558/ COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary - https://www.nature.com/articles/s41416-021-01361-6) Previous lung disease and lung cancer risk: a systematic review and meta-analysis - https://pubmed.ncbi.nlm.nih.gov/21483846/ UK Radon Awareness Week Now in its seventh year, UK Radon Awareness Week is a campaign that was founded by the UK Radon Association and adopted by Public Health England and other bodies such as BRE as a week to focus on the issue and features in the National Radon Action Plan (https://www.gov.uk/government/publications/uk-national-radon-action-plan) (Added: Sat Oct 30 2021 Hits: 12 Rating: 0.00 Votes: 0) Rate It

• Don't Delay Campaign Launched To Tackle Radon-Induced Lung Cancer - During UK Radon Awareness Week (1st – 7th Nov), experts are highlighting the impact that the COVID-19 pandemic has had on lung cancer detection, diagnosis and treatment times and urging members of the public not to delay taking steps to protect their lungs • A UK Lung Cancer Coalition report suggests that lung cancer is one of the worst affected cancer pathways due to a combination of factors, including overlapping symptoms with COVID-19 and specific pressures on respiratory health-care services caused by the pandemic. • According to an article published in the British Journal of Cancer, the pandemic is having profound effects on both diagnosis and treatment strategies • Don’t Delay campaign urges public to test homes for radon, the leading cause of lung cancer in non-smokers and to see their GP if they develop lung cancer symptoms • Radon is the leading cause of lung cancer after smoking and is responsible for over 1100 deaths in the UK every year. “During the first wave of the pandemic, public fear of engaging with health services, halting of the national programme of lung cancer screening pilots, and restricted access to diagnostic tests contributed to a 75% drop in urgent lung cancer referrals,” said Robert Rintoul, Chair of the UK Lung Cancer Coalition Clinical Advisory Group. “Guidance to stay at home with a cough, a key symptom of lung cancer, also caused further confusion among the general public. As a result of the reduction in referrals we are now seeing an increase in late-stage presentations which will potentially lead to hundreds of additional deaths, reversing the significant progress that has been achieved in improving lung cancer survival over the last 10–15 years.” In August 2021, the NHS launched its ‘Help Us, Help You’ campaign with the aim of persuading people exhibiting possible lung cancer symptoms to contact their GP. To further enhance this message, the UK Radon Association is today launching its Don’t Delay campaign. Rebecca Coates, Chair of UK Radon Association said, “Lung cancer is often still thought of as a smoker’s disease, however sadly rates in non-smokers are increasing. Lung cancer is not the immediate thought for a non-smoker with a persistent cough, even less so whilst COVID-19 is a possible cause. That’s why we’ve launched the Don’t Delay campaign to raise awareness not only of the need to visit your GP if you have symptoms, but also that everyone should consider testing their home for radon to protect their lungs.” Radon is a radioactive gas we can’t see, smell or taste. It comes from the rocks and soil found everywhere in the UK and can enter your building without you knowing. The only way to know if a building has a high radon level is to have it tested, which costs about £50. According to the UK Health Security Agency, radon produces tiny radioactive particles in the air we breathe which damages our lung tissue and, over a long period, may cause lung cancer. The higher the level and the longer the period of exposure, the greater the risk. At the recent UK Radon Symposium, keynote speaker Dr Aaron Goodarzi, Canada Research Chair for Radiation Exposure Disease drew attention to findings that previous lung disease, including pneumonia, bronchitis and COPD, leads to an increased risk of an individual developing lung cancer in the future. Dr Goodarzi warned that the number of patients suffering with so-called ‘Long Covid’ globally will have widespread ramifications on lung cancer rates. ENDS Contact: Rebecca Coates – UK Radon Association Chair chairman@radonassociation.co.uk or 07931 702948 Notes to Editors The Don’t Delay campaign video is available at https://youtu.be/Y27vOdz_LOE References Radon and Public Health - Report of the Independent Advisory Group on Ionising Radiation https://www.gov.uk/government/publications/radon-and-public-health COVID-19 Matters: A Review of the Impact of COVID-19 on the Lung Cancer Pathway and Opportunities for Innovation Emerging from the Health System Response to the Pandemic - https://www.uklcc.org.uk/wp-content/uploads/2020/10/UKLCC-COVID-19-Matters-Report-Oct-2020.pdf Lung cancer control in the UK hit badly by COVID-19 pandemic - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832558/ COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary - https://www.nature.com/articles/s41416-021-01361-6) Previous lung disease and lung cancer risk: a systematic review and meta-analysis - https://pubmed.ncbi.nlm.nih.gov/21483846/ UK Radon Awareness Week Now in its seventh year, UK Radon Awareness Week is a campaign that was founded by the UK Radon Association and adopted by Public Health England and other bodies such as BRE as a week to focus on the issue and features in the National Radon Action Plan (https://www.gov.uk/government/publications/uk-national-radon-action-plan) (Added: Sat Oct 30 2021 Hits: 14 Rating: 0.00 Votes: 0) Rate It

• Best Marijuana Dispensary in Orange County - Welcome to basicCure! We are the best cannabis delivery in Orange County. Servicing the community since 2015. We believe in consistency and reliability. Our cannabis is hand crafted to a level of boutique quality. We strive in bettering ourselves and providing only the freshest and highest quality product. Our team is innovative and the results are always the best quality around. Our new strain Dolato, also known as "Do-Si-Lato" and "Dosi-Lato," is an indica marijuana strain made by crossing Do-Si-Dos with Gelato #41. Dolato has a beautiful range of colors in its colas—from light to dark green and red-wine purple to bright orange, all dusted with diamond-like trichomes. Dolato’s terpene profile features a fruity, earthy scent followed by a sweet lavender taste. Dolato may leave people feeling stress-free and sedated, making it perfect for a slowed-down night in, perhaps paired with a bath and a book. We carry powerful hybrid/sativa called Gelonade. It is a hybrid marijuana strain made by crossing Lemon Tree with Gelato #41. Gelonade produces tingly and uplifting effects that will make you feel like a social butterfly. This strain features mostly sweet flavors like fruity citrus and vanilla. Gelonade is a popular strain in California. Medical marijuana patients this strain to help relieve symptoms associated with pain and anxiety. This is just a few of many strains that basicCure delivers. We carry vape cartridges. Our team partnered up with Bloom. Made with ~40-80 terpenes per strain, Bloom Vape offers the most flavorful puffs and authentic effects in a discreet, convenient design. basicCure delivers fresh budder featuring micro diamonds, produced by the innovative Big Oil Company. Enjoy our curated limited-edition strains today. BasicCure carries premium joints at mid shelf pricing. Each joint contains 1 gram of potent (over 20% THC) flower for a clean, smooth burn and long-last high. basicCure has the marijuana deals in Huntington Beach. On-demand weed for when you've got that 420 feeling. basicCure services are fast, affordable, and if you order, they’re sales-tax and city-tax-free! Every day, basicCure offers their customers the chance to order their favorite – always affordably priced – products without paying the usual 19.5% combined sales and state tax. If you buy in bulk, it’s especially worth looking into this deal! Some people are hesitant to take advantage of deals or discounts because they think they won’t save that much or will be inconvenienced for the sake of saving a few bucks. In truth, it isn’t just easy to save on weed. It’s worth it, especially when you sit down and look at the numbers. Let’s take a closer look together: If you were to purchase an eighth of high-quality cannabis at a dispensary without a medical card, you would be charged the item’s price plus a state tax, an excise tax, and a sales tax. Let’s say that eighth costs $50. Now, add 10% city tax, 15% excise tax, and 9.5% sales tax for a grand total of $67.25. When you shop with basicCure, you can also save even more when you buy in bulk. Just like the good ol’ days, the more you buy the more you save—so you can enjoy more of your favorite products for less money! For example, if you buy an ounce instead of just an 8th, you could save up to 25%. You don’t have to settle for paying high prices to get high, nor do you have to go out of your way to take advantage of the best deals. If you plan things right, you can avoid paying sales tax, have your weed delivered directly to your door for free, and enjoy serious discounts just for trying new services! Sources: https://www.prfree.org/@basiccure/best-marijuana-dispensary-in-orange-county-63mbwq345kb7 To know more about basicCure best marijuana dispensary in Santa Ana. Visit us at https://www.basiccure.net/ (Added: Sat Oct 30 2021 Hits: 32 Rating: 0.00 Votes: 0) Rate It

• How Hydroxychloroquine Helps in the Treatment of Malaria - Hydroxychloroquine is used to treat and treat malaria caused by mosquito bites. The United States Center for Disease Control provides up-to-date guidelines as well as recommendations for travel to prevent as well as treatment for malaria in various parts of the world. This medication is also used to treat auto-immune disorders like lupus, rheumatoid arthritis. How to use Hydroxychloroquine in malaria? Use your treatment by mouth generally along with food to avoid stomach upset. Follow the exact instructions recommended by your physician. For children, the dosage is also determined by weight. To stop malaria to prevent malaria, you should take this medication via mouth according to the instructions of your physician, typically once every week on the exact date each week. Keep a calendar to remind you of. The drug is generally started about 2 to 3 weeks before entering the malarious zone. It is recommended that you continue taking it each week throughout the region and for between 4 and 8 weeks after you leave the area or as prescribed by your physician. To treat lupus or rheumatoid arthritis, take this medication via mouth according to the instructions of your physician, typically at least once or twice a day. Your doctor could gradually increase your dosage. If you've been on the medication for some time, but your health has improved, your doctor could suggest reducing your dosage until you reach the dose that has the most significant effect with the least adverse negative effects. Make sure to take this medication regularly to reap the maximum benefit. If you're using it on a regular schedule, you should take it each day at the identical time(s) every day. Use this medication as it is prescribed. Consult your physician If your condition continues or becomes worse. It could take several months or weeks to show improvements if you're using this to treat Lupus as well as arthritis. Hydroxychloroquine is not able to prevent malaria in all instances. If you are experiencing symptoms of illness, seek medical attention immediately. Available form of Hydroxychloroquine Hydroxychloroquine can be found in tablets to chew or swallow. It is recommended to begin treatment two to three weeks before you go to a region where malaria is prevalent and continue throughout your stay and for 4 weeks following your return. Suppose you're an adult who is taking Hydroxychloroquine to treat malaria. In that case, the initial dose is typically consumed immediately, and then and then a second dose is taken about 6-8 hours later and then additional doses every two days. To treat or prevent malaria in children and infants, the dosage of Hydroxychloroquine will depend on the child's weight. The doctor will calculate the amount and inform you of the amount of Hydroxychloroquine your child needs to take. If you're using Hydroxychloroquine to treat Lupus Erythematosus (DLE, also known as SLE), It is generally taken once or twice per day. If you're taking Hydroxychloroquine to treat rheumatoid arthritis, it's usually taken twice or once a day. Take the tablets and swallow them whole. Don't break or chew or crush them. Buy Hydroxychloroquine 200mg tablets are taken in conjunction with a glass of milk or as a meal to reduce nausea. If you're taking Hydroxychloroquine to treat the symptoms of rheumatoid arthritis, your symptoms will improve in the next six months. If the symptoms of rheumatoid arthritis aren't improving or worsening, stop taking the medication and contact your doctor. When you and your physician confirm that the drug is working for you, you should not discontinue taking Hydroxychloroquine until you have spoken with your physician. Rheumatoid arthritis symptoms are likely to return when you finish taking the Hydroxychloroquine. Hydroxychloroquine may cause side effects. Inform your doctor when any of the following signs are severe or don't disappear: ● Headache ● Dizziness ● Appetite loss ● Nausea ● Diarrhea ● Stomach pain ● Vomiting ● Rashes (Added: Fri Oct 29 2021 Hits: 22 Rating: 0.00 Votes: 0) Rate It

• Treatment For Psoriatic Arthritis - Psoriatic arthritis (PsA) is a type of joint pains, that affects people who have skin psoriasis — a condition with red, raised skin, with white and silvery flakes. Around 30% of psoriasis patients will develop Psoriatic Arthritis. Most people develop psoriasis first and later develop psoriatic arthritis, but the joint problems can sometimes begin before the skin psoriasis. Psoriatic Arthritis can affect any age group (from children to old age group). Symptoms- Joint pain, stiffness and swelling are the main symptoms. It can affect any joint of body. Other common symptoms include painful, sausage-like swelling of your fingers and toes (Dactylitis), heel pain (Enthesitis). Spine involvement causes neck and back pain with early morning stiffness similar to spondyloarthritis (Ankylosing spondylitis). Some patients will develop recurrent painful Red eyes with blurred vision (uveitis/iritis) and Bowel inflammation with repeated episodes of loose stool (IBD- Inflammatory Bowel disease). They are also at higher risk of cardiovascular disease and Non-Alcoholic Fatty liver disease. Arthritis mutilans a complication of PsA leads to destruction of small bones of fingers leading to severe, painful deformities of hand joints. Symptoms can range from mild to severe. In both psoriasis and psoriatic arthritis, disease flares may alternate with periods of remission. Causes JPsoriatic arthritis occurs when your body's immune system mistakenly attacks the joint and skin. Genetic and environmental factors play a role. Many people with psoriatic arthritis have a family history of psoriasis or psoriatic arthritis. Physical trauma, viral or bacterial infection — may trigger psoriatic arthritis in people with an inherited tendency. Risk factors for Psoriatic arthritis include- People who have pitted, deformed psoriatic nails and family history of psoriasis. Diagnosis Clinical examination of joints, skin and nails helps in diagnosis. No single test can confirm a diagnosis of psoriatic arthritis. But some tests can rule out other causes of joint pain, such as rheumatoid arthritis or gout. Imaging- x-rays of hands and feet, Ultrasound of joints, MRI of joints or spine Lab test- ESR, CRP, HLA B27, RA factor (to rule out rheumatoid arthritis), joint fluid analysis if needed to rule out other causes. Treatment No cure exists for psoriatic arthritis, so treatment mainly focuses on controlling inflammation in your affected joints to prevent joint pain and deformities. Medications Drugs used to treat psoriatic arthritis include: NSAIDs. Nonsteroidal anti-inflammatory drugs (NSAIDs) relieves pain and reduces inflammation. These may be prescribed for short period. Long-term usage leads to side effects like gastritis, liver and kidney damage. Disease-modifying anti-rheumatic drugs (DMARDs). These drugs slows the progression of psoriatic arthritis and save the joints from permanent damage. Common DMARDs include Methotrexate, Leflunomide, Sulfasalazine and Apremilast. Sometimes Azathioprine and Cyclosporine are also used. Side effects vary but may include liver damage, bone marrow suppression and infections. Biologic agents. These medications target specific parts of the immune system that trigger inflammation. This newer class of DMARDs includes Adalimumab, Etanercept, Golimumab, Infliximab, Ixekizumab, Secukinumab, Tofacitinib and Ustekinumab. These drugs may increase the risk of infections. Biologic agents can be used alone or combined with DMARDs such as methotrexate. Surgical and other procedures Steroid injections - injected into an affected joint, reduces the inflammation quickly. Joint replacement surgery- for severely damaged joints. Lifestyle and home remedies Protect your joints- Avoid straining your joints or lifting weights . Maintain a healthy weight, avoid stress, adequate sleep. The best way to increase nutrients while limiting calories is to eat more plant-based foods — fruits, vegetables and whole grains. Exercise regularly- To keep your joints flexible. Types of exercises that are less stressful on joints include biking, swimming and walking. Stop smoking. Smoking is associated with a higher risk of developing severe psoriasis and arthritis. Limit alcohol use. Alcohol can increase your risk of psoriasis, decrease the effectiveness of your treatment and increase side effects from medications. (Added: Fri Oct 29 2021 Hits: 17 Rating: 0.00 Votes: 0) Rate It

• Treatment for juvenile Idiopathic arthritis in Warangal - Juvenile idiopathic arthritis is a common type of arthritis that affects children; it is earlier known as juvenile rheumatoid arthritis. Children under 16 years of age are mostly affected. It is a chronic disease that affects any joint of the body. The immune system mistakenly targets synovium (synovium is a tissue that lines the inside of the joint). The synovium responds by making excess synovial fluid which leads to persistent joint pain, swelling, and stiffness. The inflammation and synovium spreads to the surrounding tissues and damage cartilage and bone. Some children may see the early symptoms only for a few months, while others have symptoms lifelong. Some categories of juvenile idiopathic arthritis can give rise to critical problems, such as growth and development problems, joint damage, and eye inflammation. Treatment is given to reduce pain and inflammation, improving the function of the joints, and preventing any further joint damage. There are many types of Juvenile idiopathic arthritis they are: - Systemic arthritis, Oligoarthritis, Polyarthritis, Psoriatic arthritis, Enthesitis-related arthritis. Symptoms of JIA: Depends on the type of JIA, the symptoms vary. Common symptoms are Morning stiffness: you might have noticed that your child is unable to walk especially in the morning. Pain: the child appears clumsier than usual mainly in the mornings and after taking nap. Swelling and tenderness in the joints: it is mostly noticed in the larger joints such as knee. Limping, fever, rash, weight loss, fatigue, eye redness, and blurred vision: these symptoms usually worsen in the evenings. Based on the symptoms and the number of joints affected the type of disease is identified. Symptoms come and go over days or weeks. When the child has less fever it seems to be fine. When it flares up, the child will feel sick. Children will have good days with very few or without any symptoms, and worse days with flare up symptoms.This condition might cause inflammation in the lining of the lung (pleuritis) or heart (pericarditis). It may also cause swollen lymph nodes. Children with these conditions may grow slowly than normal. Causes: Juvenile idiopathic arthritis occurs when our own body's immune system attacks its own cells and tissues. Research indicates that it is an autoimmune disease. White blood cells can’t tell the difference between healthy cells and germs. Instead of protecting from these harmful invaders, it damages healthy tissues and cause inflammation and pain. It's unknown why this happens, but both heredity and environment seem to play a vital role in causing the disease. Certain gene mutations may make a person more vulnerable to environmental factors like viruses that are the triggering source of the disease. (Added: Fri Oct 29 2021 Hits: 19 Rating: 0.00 Votes: 0) Rate It

• U.S. Home Infusion Therapy Market is Dazzling Worldwide - This published report for the U.S. Home Infusion Therapy Market Size Size Industry analyzes and forecasts the marketing statistics of the product/service market on a global as well as the regional level. This detailed study U.S. Home Infusion Therapy Market Size Size Industry also offers the previous historical data along with the forecast from 2021 to 2030. The assessment of the U.S. Home Infusion Therapy Market Size Size Industry factors gives a brief overview of the impact on the demand over the forecast period. In addition to this, the report also studies the opportunities that are available in the report at the global level. An executive summary is also provided based on the industry snapshot for the period from 2021-2030.  Request a Sample Copy of This Report@ https://www.absolutemarketsinsights.com/request_sample.php?id=212 Astonishing growth in Home Infusion Therapy Market Size Anticipated to Grow at a CAGR of 10.5% From 2021 to 2027 and Reach US$ 19,250.0 Million by 2030, Due to Rising Incidence of Chronic Diseases Growing rates of chronic diseases is expected to drive the U.S Home Infusion Therapy Market Size. The U.S. Home Infusion Therapy Market Size is estimated to reach a market value of US$ 8,672.3 million in 2021 and it is expected to reach US$ 19,250.0 million by 2030, growing at an estimated CAGR of 10.5% over the forecast period. Scope of the Report: Market trends impacting the growth of the global beverage stabilizers market Trends of key regional and country-level markets for type, function and application. To get a comprehensive overview of the U.S Home Infusion Therapy Market Size. Historical, current and projected market size in terms of volume and value A neutral perspective towards market performance Must-have information for market players to sustain and enhance their market footprint. The need to provide continuous care to elderly population and chronic disease patients at remote locations generates demand for various infusion therapy devices and solutions. Increasing incidences of respiratory disorders, cardiovascular diseases and other chronic ailments will result in more and more adoption of infusion products, which will thus propel the U.S. Home Infusion Therapy Market growth. Industry growth is also attributed to rising average household income across the nation and to availability of home healthcare providers. A large proportion of retired elderly population has monetary reserve to avail healthcare at their homes. In spite of many market growth favoring parameters, factors such as sporadic affordability, limitations on reimbursement and insurance restrains market expansion across the U.S. A considerable stratum of geriatric population experience home infusion therapy shortfall due to scarcity in number of home healthcare agencies in remote areas of certain states. Key Findings of the Report: Infusion pump market segment held more than 50% of market share in 2018 and is estimated to grow at CAGR of above 9% during the forecast period. Infusion pump growth is attributed to introduction of modern pumps that offer low error while administrating nutritional fluids. Increasing prevalence of disease prone to geriatric population will fuel Home Infusion Therapy Market Size growth in near future. Needleless connectors market segment is estimated to grow with CAGR of above 10% over the projection timeframe, owing to rising demand for home infusion therapy caused due to diseases such as dengue, malaria etc. Population suffering from such diseases require continuous administration of external nutritional fluids. More the need for home infusion, more will be the demand for needleless connectors. Application of home infusion therapy for anti-infective diseases held the largest market share in 2018 and it is estimated to continue its dominance over the forecast period. Rising rate of various infectious diseases caused by virus, bacteria and others will augment demand for anti-infective home infusion therapy products. Pacific central region Home Infusion Therapy Market Size is expected to witness the highest growth rate over the forecast period. Increasing demand for various home infusion therapy will contribute to market growth in this region. Key industry participants in U.S. Home Infusion Therapy Market Size are Baxter International, Becton Dickinson, Fresenius Kabi, Smith Medical, B. Braun, Amsino International, Halyard Health and Terumo Corporation among others. Partnership, collaboration, expansion and acquisition are some of the strategies adopted by companies to expand their reach and gain competitive advantage. Inquiry Before Buying This Report@ https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=212 Home Infusion Therapy Market Size By Product Infusion pumps Intravenous sets IV cannulas Needleless connectors Home Infusion Therapy Market Size By Application Anti-infectives Hydration therapy Chemotherapy  Enteral nutrition Parenteral nutrition Specialty pharmaceuticals  Others Home Infusion Therapy Market Size By Geography East North Central West South Central South Atlantic North East East South Central West North Central Pacific Central Mountain States Contact Us: Company: Absolute Markets Insights Email id: sales@absolutemarketsinsights.com  Phone: +91-740-024-2424 Contact Name: Shreyas Tanna The Work Lab,  Model Colony, Shivajinagar, Pune, MH, 411016 Website: https://www.absolutemarketsinsights.com/  (Added: Thu Oct 28 2021 Hits: 15 Rating: 0.00 Votes: 0) Rate It

• Best doctor for arthritis in Warangal - Rheumatoid arthritis (RA) is an inflammatory arthritis in which joints of the hands and feet, are inflamed, which results in joint pains, swelling and frequent destruction of joints. Small joints of the limbs become painful and have stiffness which persists for about 60 minutes on awakening and after inactivity. Due to weakness, fever and damage to other organs may also occur. RA affects both sides of the body. For example, if a joint is affected in one arm or leg then a similar joint of the other arm or leg will be affected too. This is one of the ways RA is identified by the doctors from other forms of arthritis like Osteoarthritis (OA). Rheumatoid arthritis develops in about 1% in the whole world’s population. Women are affected 2 times more than men. It appears in the age group between 35 to 50years. A similar disease in children may occur which is known as Juvenile idiopathic arthritis. The cause of Rheumatoid arthritis is not known, it is considered as an autoimmune disease. The components of the immune system attack the soft tissues and will also attack the connective tissue in other parts of the body such as blood vessels and lungs. Due to this, gradually the bone, cartilage and the ligaments of the joints wear away causing deformity. Many unknown factors like viral infections and smoking play a vital role. Treatments work best when RA is identified at an early stage, so it’s significant to learn the signs. Read on to acquire all you want to know about RA, from kinds and indications, to home remedies, diets, and other treatments. Symptoms: People who have RA may experience these symptoms: Joint pain, fatigue, Joint tenderness, Joint swelling, redness in joints, Joint stiffness, Loss of joint function, limping, joint deformity, both sides of the joints affected, Anemia, Fever, Depression. Some may feel tired and weak by afternoon. RA may also cause loss of appetite with weight loss. The signs and symptoms of RA may vary from person to person. Intense RA symptoms are known as flare-ups, and inactive periods. Other times when symptoms are less is known as remission. (Added: Thu Oct 28 2021 Hits: 12 Rating: 0.00 Votes: 0) Rate It

• 11 Tips For People Taking Care Of Loved Ones With Dementia - According to the Alzheimer’s Society, about 850,000 people have dementia in the UK — and about a third of them are receiving dementia Care Kent in residential settings. Are you providing care and support to a loved one with dementia? Here are 11 tips to help you. Know your loved one’s specific circumstances. Providing live in care Sevenoaks to dementia patients depends on what stage they’re in. Early-stage dementia patients can still live independently but may need help with things that they’re forgetting. Those in the moderate stage mainly have difficulty getting dressed or are becoming increasingly restless. Late-stage dementia entails that patients should receive 24/7 care. Understand their changing needs. There’s still no cure for dementia today. The least that you can do is prevent symptoms from worsening and help the patient live well with dementia. To do so, you have to be there to help them cope with their changing needs (e.g. When they need assistance with practical things or when they experience sadness and frustration). Talk about it with your family members. It takes more than one person to take care of someone with dementia. Have regular meetings with your household so you can better strategise how to care for and live with someone with dementia. Utilise available resources. From researching resources from groups like Alzheirmer’s Society to asking for practical tips from your circle or acquaintances, maximise all the available resources out there to your benefit. Keep a routine. As recommended by professionals providing live in care Sevenoaks, it’s helpful to establish a routine with dementia patients. When you bathe and groom them, help them eat, and give them medicine at the same time of the day, it will provide them with a sense of familiarity. Buy easy-to-use clothing. Mobility is essential when taking care of dementia patients. But it’s not just you who needs to be in comfortable clothing — the everyday of your loved one with this disease if they wear something that’s easy to wear and remove (loose clothes, clothes with elastic waistbands). Make your home dementia-friendly. Repair any damaged structures that can cause injury to the patient. Keep walkways unobstructed and make sure that the house is well-lit and free of slippery flooring products and accessories. Get rid of clutter as it may prompt confusion. Help them eat healthily. Dementia patients need to avoid foods with high saturated fat and cholesterol. Leafy greens, nuts, berries, and those rich in Omega-3 are good for their health. Take care of yourself, too. You shouldn’t compromise your health in the process. Eat healthily, maintain proper hygiene, and take regular breaks. Staying fit is essential so you can be effective in taking care of your loved one. Get professional dementia care service. Always know when you need reinforcements. Keep in mind that you’re not alone in your effort to help your loved one live well with dementia. There are reputable agencies that specialise in giving live in care to people with this and other related conditions. Stay positive. Optimism is important when caring for someone with dementia. Through it, you can remain gentle and respectful when dealing with them. Enlist Top-Notch Dementia Care If you’re taking care of someone with dementia at home, you don’t have to be alone. Vitality Live in Care is ready and committed to providing the support that you need. Their live-in care package is inclusive of a private general practitioner at no extra cost. Learn more at https://vitalityliveincare.co.uk/live-in-dementia-care. Get in touch with them at 01732 757959 or contact@vitalityliveincare.co.uk. (Added: Thu Oct 28 2021 Hits: 18 Rating: 0.00 Votes: 0) Rate It

• 9 Benefits Of Live-In Care Services For Patients With Alzheimer's - Managing and caring for patients with Alzheimer’s is no easy feat, and not something any individual can do. That is often why people seek caretaking services for those afflicted with Alzheimer’s. If you are wondering if Alzheimers care in Kent is worth it, take a look at these reasons why.
  
  1. A familiar environment
  
  With live-in care services, there is no need to have the patient move from a comforting and familiar place, to a new and unfamiliar environment. This may often worsen their condition due to additional stress.
  
  2. No safety concerns
  
  A great worry for most people who have experienced a loved one’s encounter with Alzheimer’s is their immediate safety. This disease often puts people who suffer from it in danger, especially when they experience bouts of confusion, mood swings, or memory loss.
  
  3. Encourage social behaviour
  
  A big help to those suffering from Alzheimer’s is social interaction. Mental stimulation helps keep the brain active, as the condition tends to worsen in isolated situations. A live-in caretaker will keep the patient company and encourage meaningful, social behaviour.
  
  4. Less day-to-day worries
  
  Having someone live-in with the Alzheimer’s patient ensures that they are well taken care of. They will have someone around who is able to ensure that they receive the proper care and the attention that they need to ensure the condition does not progress rapidly.
  
  5. Monitored health status
  
  The patient benefits from having a live-in caretaker who will also ensure that they are frequently monitored. Their mental and physical health are at risk with Alzheimer’s, and they must have regular check-ups and monitoring to ensure that their condition does not worsen their health.
  
  6. Promote routines
  
  Another type of mental stimulation that the patient may benefit from is a routine. Having someone around to help set a routine helps the patient feel a semblance of familiarity; this encourages a sense of familiarity, and alleviates stress from what they would consider "new" situations.
  
  7. Specialized home care services
  
  Having a live-in caretaker means that there is a screening process that you go through with a list of potential candidates. This gives you, and the patient, the ability to siphon through the candidates and choose the one most able to give exactly the type of care that the patient wants or needs.
  
  8. Round the clock care taking
  
  Because the caregiver lives with the patient, they are able to ensure that they are given the best care around the clock. Alzheimer’s care is not easy in the slightest, and often requires monitoring 24/7, and a live-in caregiver is able to provide that for the patient.
  
  9. Resting easy
  
  Both you and the patient can rest easy with a live-in caregiver for Alzheimer’s patients. They are professional, experienced, and are trained to ensure that the patient’s quality of life is at the best standards possible.
  
  The benefits of a live-in caretaker for Alzheimer’s care Kent are great. Once you have screened your possible applicants, you can be sure that your loved ones are able to live the best life that they can live, despite their illness.
  
  For Alzheimers care Kent, contact Chrysalis Care today via 1093264-5 or visit https://chrysaliscareathome.org/ to learn more about their services. (Added: Wed Oct 27 2021 Hits: 13 Rating: 0.00 Votes: 0) Rate It

• Lupus Treatment in Warangal - Lupus is a systematic autoimmune disease which affects the body’s tissues and organs by your own immune system thinking that they are foreign. Lupus is a chronic inflammatory disease that affects various parts of the body including joints, skin, kidneys, blood cells, brain, heart, and lungs. Lupus is also known as systemic lupus erythematosus or SLE. The exact cause of lupus is very difficult to diagnose, although it’s a combination of genes, hormones and environmental factors. It affects women between 18 and 40 years of age. Symptoms of lupus is unpredictable, a combination of medications and lifestyle changes can make the person lead a normal life. Lupus is a chronic inflammatory disease with many health risks like cardiovascular disease, kidney disease and stroke. There is a chance of developing atherosclerosis, mayocarditis and endocarditis, which can lead to heart murmurs. Today, doctors recognize the condition at early stages and there are many ways to manage this disease compare to earlier. Almost the success rate is more than 90%. How immune system works: Our immune system protects our body by producing antibodies which attack bacteria and viruses. However, people with lupus produce antibodies that attack their own tissues. These antibodies will cause pain, inflammation and also damage other parts of the body. Causes of Lupus: Doctors don’t know the exact reason behind lupus. They think that this autoimmune disease is caused due to genetics, hormones and environment. So if your parents have this disease, you may also likely to develop lupus. However, genes alone are not the reason to get lupus, it occurs due to many other factors which are not yet identified. Other factors which may trigger lupus are Exposure to sunlight, which is common cause of flare-ups. Long term medications or antibiotics may trigger lupus. Viral infections and stress Hormone estrogen may be a reason for lupus because 9 out of 10 are women who are affected. Men and women both make estrogen, but women make more. But this doesn’t conclude that estrogen alone causes lupus. (Added: Tue Oct 26 2021 Hits: 19 Rating: 0.00 Votes: 0) Rate It

Pages: [<<] ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 ... [>>]